logo

Category : Pharmaceutical Sector

13 Feb 2019

The growing UK Cell and Gene Therapy Market

Over nine hundred companies across the globe are currently involved in cell and gene therapy and this has been increasing year on year, making it a high growth, high value market. The rising prevalence of chronic diseases and cancer have been some of the key driving factors of this rapid growth. Over the past few years there have been significant and promising developments; the first two commercially available CAR T-cell therapy products (Novartis’ Kymriah and Gilead’s Yescarta) were approved in […]

27 Jul 2018

Evolving Trends in the Global CDMO Market

“CDMOs constitute a critical resource for pharmaceutical companies to overcome their current challenges, driving down costs, reducing timelines and delivering the necessary expertise to bring new drugs to market.”[i] Growth in the global Contract Development & Manufacturing Organization (CDMO) market is, in its nature, inexorably tied to the ever-changing trends in the global pharmaceutical industry. A shift in the latter will inevitably cause waves in the former. As recent reports suggest, the global pharmaceutical market is set to continue upon […]

06 Apr 2018

Medical Devices: Deadlines are looming

If you are working within the Medical Devices industry you will understand it is going through a period of tremendous transformation; over the next six years we are facing several changes in legislation around the regulation of devices and the numerous deadlines to meet to ensure the products remain safe and compliant.   Firstly, it is important to understand the legislation which is affecting the Medical Devices industry: Almost every organization with a device on the market are now seeing […]